Go Pro
NYSE:PHR

Phreesia (PHR) Stock Price, News & Analysis

Phreesia logo
$11.47 -0.11 (-0.94%)
Closing price 03:59 PM Eastern
Extended Trading
$11.27 -0.20 (-1.75%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Phreesia Stock (NYSE:PHR)

Advanced

Key Stats

Today's Range
$11.35
$11.81
50-Day Range
$8.94
$12.64
52-Week Range
$7.77
$32.76
Volume
1.61 million shs
Average Volume
710,667 shs
Market Capitalization
$709.02 million
P/E Ratio
76.47
Dividend Yield
N/A
Price Target
$16.65
Consensus Rating
Hold

Company Overview

Phreesia, Inc. (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems. Its platform supports specialty-specific intake workflows for outpatient clinics, health systems, physician practices and academic medical centers. In addition to core registration features, Phreesia provides clinical screening, automated reminders and compliance monitoring to help providers meet quality and regulatory requirements.

Phreesia’s subscription-based model includes fees for device infrastructure and per-session charges for patient engagements. The company serves a broad customer base—ranging from small practices to large integrated delivery networks—and has expanded partnerships with payers to deliver membership and risk-adjustment tools. This extended ecosystem approach enables Phreesia to capture patient-reported data that informs both care delivery and revenue cycle management.

Under the leadership of founder and CEO Chaim Indig, Phreesia has grown its platform deployment to thousands of clinical sites across the United States. The company continues to invest in product innovation—leveraging analytics and patient-generated insights—to drive digital transformation in healthcare, enhance operational efficiency and support better financial and clinical outcomes for providers.

AI Generated. May Contain Errors.

Phreesia Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
91st Percentile Overall Score

PHR MarketRank™: 

Phreesia scored higher than 91% of companies evaluated by MarketBeat, and ranked 44th out of 909 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Phreesia has received a consensus rating of Hold. The company's average rating score is 2.42, and is based on no strong buy ratings, 9 buy ratings, 9 hold ratings, and 1 sell rating.

  • Upside Potential

    Phreesia has a consensus price target of $16.65, representing about 45.1% upside from its current price of $11.47.

  • Amount of Analyst Coverage

    Phreesia has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Phreesia's stock forecast and price target.
  • Earnings Growth

    Earnings for Phreesia are expected to grow by 76.92% in the coming year, from $0.39 to $0.69 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Phreesia is 76.47, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.60.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Phreesia is 76.47, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 270.60.

  • Price to Book Value per Share Ratio

    Phreesia has a P/B Ratio of 2.05. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Phreesia's valuation and earnings.
  • Percentage of Shares Shorted

    4.96% of the float of Phreesia has been sold short.
  • Short Interest Ratio / Days to Cover

    Phreesia has a short interest ratio ("days to cover") of 4.16.
  • Change versus previous month

    Short interest in Phreesia has recently decreased by 17.36%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Phreesia does not currently pay a dividend.

  • Dividend Growth

    Phreesia does not have a long track record of dividend growth.

  • News Sentiment

    Phreesia has a news sentiment score of 0.86. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.70 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Phreesia this week, compared to 8 articles on an average week.
  • Search Interest

    8 people have searched for PHR on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Phreesia insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $39,125.00 in company stock.

  • Percentage Held by Insiders

    5.20% of the stock of Phreesia is held by insiders.

  • Percentage Held by Institutions

    92.10% of the stock of Phreesia is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Phreesia's insider trading history.
Receive PHR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Phreesia and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PHR Stock News Headlines

The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel
See More Headlines

PHR Stock Analysis - Frequently Asked Questions

Phreesia's stock was trading at $16.91 at the beginning of the year. Since then, PHR stock has decreased by 32.2% and is now trading at $11.4710.

Phreesia, Inc. (NYSE:PHR) issued its earnings results on Wednesday, May, 27th. The company reported $0.05 EPS for the quarter, beating analysts' consensus estimates of $0.02 by $0.03. The business's revenue was up 12.9% compared to the same quarter last year.
Read the conference call transcript
.

Phreesia (PHR) raised $149 million in an initial public offering (IPO) on Thursday, July 18th 2019. The company issued 9,288,194 shares at a price of $15.00-$17.00 per share. J.P. Morgan, Wells Fargo Securities, William Blair, Allen & Company and Piper Jaffray served as the underwriters for the IPO.

Top institutional shareholders of Phreesia include BlackRock Inc. (11.36%), Algert Global LLC (1.95%), Connor Clark & Lunn Investment Management Ltd. (0.99%) and Bank of America Corp DE (0.95%). Insiders that own company stock include Chaim Indig, Evan Roberts, David Linetsky, Amy Beth Vanduyn, Allison C Hoffman, Balaji Gandhi, Michael Weintraub, Michael J Davidoff, Lisa Egbuonu-Davis, Mark Douglas Smith, Janet Gunzburg and Yvonne Hui.
View institutional ownership trends
.

Shares of PHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Phreesia investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), CrowdStrike (CRWD), Arista Networks (ANET) and Palo Alto Networks (PANW).

Company Calendar

Last Earnings
5/27/2026
Today
8/18/2026
Next Earnings (Estimated)
9/02/2026
Fiscal Year End
1/31/2027

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Technology
Sub-Industry
Healthcare Technology
Current Symbol
NYSE:PHR
CIK
1412408
Employees
1,789
Year Founded
2005

Price Target and Rating

High Price Target
$34.00
Low Price Target
$9.00
Potential Upside/Downside
+45.1%
Consensus Rating
Hold
Rating Score (0-4)
2.42
Research Coverage
19 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.15
Trailing P/E Ratio
76.47
Forward P/E Ratio
29.41
P/E Growth
N/A
Net Income
$2.31 million
Net Margins
1.85%
Pretax Margin
-0.21%
Return on Equity
5.13%
Return on Assets
3.12%

Debt

Debt-to-Equity Ratio
0.41
Current Ratio
1.76
Quick Ratio
1.76

Sales & Book Value

Annual Sales
$480.59 million
Price / Sales
1.48
Cash Flow
$0.70 per share
Price / Cash Flow
16.46
Book Value
$5.59 per share
Price / Book
2.05

Miscellaneous

Outstanding Shares
61,810,000
Free Float
58,598,000
Market Cap
$709.02 million
Optionable
Optionable
Beta
0.85

Social Links

7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

This page (NYSE:PHR) was last updated on 8/18/2026 by MarketBeat.com Staff.
From Our Partners